• Vinayak Kohli
    Vinayak Kohli
    • over 4 years ago
    • Practical Guidance Journal
    • pa

    Leave and Vacation Sharing and Donation Policies: Key Drafting Tips and Legal Issues

    By: Avi Meyerstein and Robert Sanders , Husch Blackwell LLP, and Stacey Bowman , Ascent Classical Academies This article provides key drafting tips and best practices for employers when drafting leave and vacation sharing and donation policies. A leave...
  • Vinayak Kohli
    Vinayak Kohli
    • over 7 years ago
    • Practical Guidance Journal
    • pa

    Top 10 Practice Tips: Real Estate Investment Trust IPOs

    By: Daniel P. Adams, Gilbert G. Menna , and Ettore A. Santucci Goodwin Procter LLP LIKE ALL IPOS, THE FUNDAMENTAL PROCESS FOR A REIT IPO involves the preparation of a registration statement (albeit on a Form S-11 instead of a Form S-1), including a...
  • Vinayak Kohli
    Vinayak Kohli
    • over 7 years ago
    • Practical Guidance Journal
    • pa

    Top Ten Practice Tips By Experts: Initial Public Offerings

    By: Arthur D. Robinson and Jonathan Ozner SIMPSON THACHER & BARTLETT LLP SENIOR EXECUTIVES AND OWNERS OF PRIVATE COMPANIES considering an initial public offering (IPO), or of public companies considering a spin-off or carve-out IPO of a subsidiary...
  • Vinayak Kohli
    Vinayak Kohli
    • over 4 years ago
    • Practical Guidance Journal
    • pa

    Compliance Tips for Running Clinical Trials During COVID-19

    By: Jill E. Anderson , Linda A. Malek , and Nora Lawrence Schmitt , Moses & Singer LLP NAVIGATING THE PATH FORWARD TO CONDUCT CLINICAL research in the midst of the COVID-19 pandemic has introduced unique challenges for sponsors and research institutions...
  • Vinayak Kohli
    Vinayak Kohli
    • over 6 years ago
    • Practical Guidance Journal
    • pa

    Pharmaceutical Patent Litigation Strategies

    By: Jeffrey Alan Hovden, Robins Kaplan LLP This article discusses strategies that counsel for brand-name and generic drug companies may employ in pharmaceutical patent litigation under the Drug Price Competition and Patent Term Restoration Act of 1984...
<>